$MDXH News
Last published 1w ago
- 1w agoMDXHMdxhealth to Release Third Quarter 2026 Financial Results on November 12GlobeNewswireCompany to Host Conference Call with Live Q&A, November 12, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – October 29, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ:MDXH), a leading precision diagnostics
- 3w agoMDXHMDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue GuidanceGlobeNewswireIRVINE, CA – October 15, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced preliminary unaudited revenue
- 2mo agoNTHIMDXHCAPRONFOThese Biotech Breakouts and Squeeze Setups Could Be Just Getting StartedGlobeNewswireDENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- Today’s stock market coverage illustrates two very different kinds of momentum. NeOnc (NASDAQ:NTHI), MDxHealth (NASDAQ:MDXH), and Capricor Therapeutics
- 3mo agoMDXHMdxhealth Reports Second Quarter 2026 Financial ResultsGlobeNewswireSecond quarter revenue growth of 16% to $27.2 millionConference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE, California – August 13, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the
- 3mo agoMDXHMdxhealth to Release Second Quarter 2026 Financial Results on August 13GlobeNewswireCompany to Host Conference Call with Live Q&A, August 13, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – July 30, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ:MDXH), a leading precision diagnostics company,
- 3mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsHello and welcome. I am Denae Wells, the GPS Marketing Product Manager at MDX Health. As you guys all know, prostate cancer decisions are not one size fits all. Two men with the same risk score can face very different fu
- 3mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsHello and welcome. I am Denae Wells, the GPS Marketing Product Manager at MDX Health. As you guys all know, prostate cancer decisions are not one size fits all. Two men with the same risk score can face very different fu
- 3mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsHello and welcome. I am Denae Wells, the GPS Marketing Product Manager at MDX Health. As you guys all know, prostate cancer decisions are not one-size-fits-all. Two men with the same risk score can face very different fu
- 4mo agoMDXHMdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyGlobeNewswireIRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received
- 4mo agoMDXHMdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled TrialGlobeNewswireMdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial IRVINE, California –
- 5mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsOkay. It looks like we have several of our attendees that have joined this evening, so I'm going to go ahead and kick us off. I am honored to introduce Dr. Jose De La Cerda that has joined us this evening. He is from San
- 5mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsOkay. It looks like we have several of our attendees that have joined this evening, so I'm going to go ahead and kick us off. I am honored to introduce Dr. Jose De La Cerda that has joined us this evening. He is from San
- 6mo agoMDXHMdxhealth Reports Q1-2026 ResultsGlobeNewswireMdxhealth Reports Q1-2026 Results Conference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, California – May 13, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ:MDXH) (the "Company" or
- 6mo agoMDXHMdxhealth to Release First Quarter 2026 Financial Results on May 13GlobeNewswireMdxhealth to Release First Quarter 2026 Financial Results on May 13 Company to Host Conference Call with Live Q&A, May 13, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – April 30, 2026 (GlobeNewswire) –
- 8mo agoMDXHMdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026GlobeNewswireMdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 IRVINE, California – March 16, 2026
- 8mo agoMDXHMdxhealth Announces Fourth Quarter and Full-Year 2025 Financial ResultsGlobeNewswireMdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results Fourth quarter revenue growth of 19% to $29.5 million2025 revenue growth of 20% to $107.9 millionConference call with Q&A today at 4:30 PM EST
- 9mo agoMDXHMdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26GlobeNewswireMdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET / 22:30 CET IRVINE,
- 9mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsHello everyone and welcome to today's webinar. I'm here with Dr. Weiner. I wanted to let everyone know if you do have any questions today, please submit them through the chat. We will have some time at the end to go over
- 9mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsWelcome to Uncovering Hidden Aggression, GPS MDX Studies on Adverse Pathology Revisited. I'm Danai Wells. I'm the GPS Marketing Product Manager. We are very fortunate to have this expert panel here with us today to both
- 9mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsOkay. I am going to kick us off. Good evening. For all those that have been able to join tonight, we are very fortunate to have Dr. Jamie Kearns joining us. He is a true expert in prostate cancer and prostate-related con
- 9mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsWelcome to Uncovering Hidden Aggression, GPS MDX Studies on Adverse Pathology Revisited. I'm Danai Wells. I'm the GPS Marketing Product Manager. We are very fortunate to have this expert panel here with us today to both
- 9mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsHello everyone and welcome to today's webinar. I'm here with Dr. Weiner. I wanted to let everyone know if you do have any questions today, please submit them through the chat. We will have some time at the end to go over
- 9mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsWelcome to Uncovering Hidden Aggression, GPS MDX Studies on Adverse Pathology Revisited. I'm Danai Wells. I'm the GPS Marketing Product Manager. We are very fortunate to have this expert panel here with us today to both
- 9mo agoMDXHEarnings Call - MDXHEALTH SAEarnings Call TranscriptsOkay. I am going to kick us off. Good evening. For all those that have been able to join tonight, we are very fortunate to have Dr. Jamie Kearns joining us. He is a true expert in prostate cancer and prostate-related con
- 10mo agoMDXHMDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact SciencesGlobeNewswireMDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences IRVINE, CA – January 12, 2026 (GlobeNewswire) – MDxHealth SA
- 12mo agoMDXHMdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025GlobeNewswireMdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 millionAdjusted EBITDA profitability of $1.0 million for Q3Acquisition of ExoDx
- 1y agoMDXHMdxhealth to Release Third Quarter 2025 Financial Results on November 12GlobeNewswireMdxhealth to Release Third Quarter 2025 Financial Resultson November 12 Company to Host Conference Call with Live Q&A, November 12, 2025, at 4:30pm ET / 22:30 CET IRVINE, California – November 3, 2025
- 1y agoMDXHMdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-TechneGlobeNewswireMdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or
- 1y agoMDXHMdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-TechneGlobeNewswireMdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne Year-over-year Q2 revenues increased by 20% to $26.6
- 1y agoCTKBMDXHMdxhealth Appoints Michael Holder to Board of Directors and Announces Management ChangeGlobeNewswireIRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of
- 1y agoMDXHMDxHealth Reports Q1-2025 ResultsGlobeNewswireYear-over-year Q1 revenues increase by 22% to $24.3 million71% year-over-year improvement in adjusted EBITDA in first quarterConference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM
- 1y agoMDXHMdxhealth to Release First Quarter 2025 Financial Results on May 14GlobeNewswireCompany to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET IRVINE, California – April 30, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH), a leading precision diagnostics company,
- 1y agoMDXHMdxhealth Announces Fourth Quarter and Full-Year 2024 Financial ResultsGlobeNewswireFourth quarter revenue growth of 28% to $24.7 million2024 revenue growth of 28% to $90.0 million68% improvement in adjusted EBITDA in fourth quarterConference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE,
- 1y agoMDXHMdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26GlobeNewswireCompany to Host Conference Call with Live Q&A, February 26, 2025, at 4:30pm ET / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM – February 12, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH), a leading precision
- 1y agoMDXHMDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue GuidanceGlobeNewswireMDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance IRVINE, CA – January 13, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company"
- 1y agoMDXHMDxHealth to Participate in Piper Sandler Healthcare ConferenceGlobeNewswireMDxHealth to Participate in Piper Sandler Healthcare Conference IRVINE, CA – November 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leading precision
- 2y agoMDXHMDxHealth SA (MDXH) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMDXHMDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024GlobeNewswireTissue-based test volumes increase by 36%, liquid-based test volumes by 24% Company raises 2024 revenue guidance to $87-89 million, representing 25% growth Pro-forma cash of $53.5 million Conference call and webcast
- 2y agoMDXHMDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6GlobeNewswireMDxHealth to Present Third Quarter 2024 Financial Resultsand Corporate Update on November 6 Company to Host Conference Call with Live Q&A, November 6, 2024, at 4:30pm ET / 22:30 CET IRVINE, CA, and HERSTAL, BELGIUM
- 2y agoMDXHMDxHealth Announces Pricing of Offering of Ordinary SharesGlobeNewswireMDxHealth Announces Pricing of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM – September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision
- 2y agoMDXHMDxHealth Announces Launch of Offering of Ordinary SharesGlobeNewswireMDxHealth Announces Launch of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM –September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision
- 2y agoMDXHMDxHealth SA (MDXH) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMDXHMDxHealth Reports Q2 and Half Year 2024 ResultsGlobeNewswireMDxHealth Reports Q2 and Half Year 2024 Results Year-over-year Q2 revenues increase by 32% to $22.2 millionYear-over-year H1 revenues increase by 34% to 42.0 millionConference call with Q&A today at 4:30 PM ET /
- 2y agoMDXHMDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21GlobeNewswireMDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21 Company to Host Conference Call with Live Q&A, August 21, 2024, at 4:30pm ET / 22:30 CET IRVINE,
- 2y agoMDXHMdxhealth Appoints Sanford J. Siegel, M.D. to Board of DirectorsGlobeNewswireMdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or
- 2y agoMDXHMDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue GuidanceGlobeNewswireMDxHealth Reports Preliminary Q2 and Half Year 2024 Revenuesand Raises 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH), a
- 2y agoMDXHMdxhealth to Present at Upcoming Investor ConferencesGlobeNewswireMdxhealth to Present at Upcoming Investor Conferences IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 (GlobeNewswire) – Mdxhealth SA (NASDAQ:MDXH), a commercial-stage precision diagnostics company, today
- 2y agoMDXHMDxHealth SA (MDXH) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoMDXHMDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMedGlobeNewswireMDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million, previously $79-81 million
- 2y agoMDXHMdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingGlobeNewswireMdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a